ArticleGastrointestinal tumors2022

Trends of Clinical Outcomes of Patients with Advanced Hepatocellular Carcinoma Treated with First-Line Sorafenib in Randomized Controlled Trials.

Timothy J Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.